These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 18952465)

  • 1. Drug-eluting stent insertion in the treatment of in-stent renal artery restenosis in three renal transplant recipients.
    Douis H; Shabir S; Lipkin G; Riley P
    J Vasc Interv Radiol; 2008 Dec; 19(12):1757-60. PubMed ID: 18952465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirolimus-eluting stent placement for refractory renal artery in-stent restenosis: sustained patency and clinical benefit at 24 months.
    Lookstein RA; Talenfeld AD; Raju R; Vorchheimer DA; Olin JW; Marin ML
    Vasc Med; 2009 Nov; 14(4):361-4. PubMed ID: 19808721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of reoccurring instent restenosis following reintervention after stent-supported renal artery angioplasty.
    Zeller T; Sixt S; Rastan A; Schwarzwälder U; Müller C; Frank U; Bürgelin K; Schwarz T; Hauswald K; Brantner R; Noory E; Neumann FJ
    Catheter Cardiovasc Interv; 2007 Aug; 70(2):296-300. PubMed ID: 17630674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-eluting stent implantation for treatment of recurrent renal artery in-stent restenosis.
    Kakkar AK; Fischi M; Narins CR
    Catheter Cardiovasc Interv; 2006 Jul; 68(1):118-22; discussion 123-4. PubMed ID: 16763993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of drug-eluting balloon angioplasty for treatment of refractory recurrent carotid in-stent restenosis.
    Gandini R; Del Giudice C; Da Ros V; Sallustio F; Altobelli S; D'Onofrio A; Abrignani S; Vasili E; Stanzione P; Simonetti G
    J Endovasc Ther; 2014 Oct; 21(5):671-7. PubMed ID: 25290795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recalcitrant in-stent restenosis of the celiac trunk treated by drug-eluting stent.
    Visconti G; Taranto D; Briguori C
    Catheter Cardiovasc Interv; 2008 Nov; 72(6):873-6. PubMed ID: 19009632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on PADI trial: percutaneous transluminal angioplasty and drug-eluting stents for infrapopliteal lesions in critical limb ischemia.
    Martens JM; Knippenberg B; Vos JA; de Vries JP; Hansen BE; van Overhagen H;
    J Vasc Surg; 2009 Sep; 50(3):687-9. PubMed ID: 19700099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten-year experience with renal artery in-stent stenosis.
    Stone PA; Campbell JE; Aburahma AF; Hamdan M; Broce M; Nanjundappa A; Bates MC
    J Vasc Surg; 2011 Apr; 53(4):1026-31. PubMed ID: 21215576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous revascularization of persistent renal artery in-stent restenosis.
    Patel PM; Eisenberg J; Islam MA; Maree AO; Rosenfield KA
    Vasc Med; 2009 Aug; 14(3):259-64. PubMed ID: 19651676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-year analysis of the Japanese cohort from the Zilver PTX randomized controlled trial supports the validity of multinational clinical trials.
    Ohki T; Yokoi H; Kichikawa K; Kimura T; Snyder SA; Ragheb AO; O'Leary EE; Jaff MR; Ansel GM; Dake MD
    J Endovasc Ther; 2014 Oct; 21(5):644-53. PubMed ID: 25290792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-eluting stent for recurrent mesenteric artery in-stent restenosis.
    Cardaioli P; Rigatelli G; Zattoni L; Giordan M
    J Endovasc Ther; 2007 Oct; 14(5):748-51. PubMed ID: 17924744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).
    Rittger H; Waliszewski M; Brachmann J; Hohenforst-Schmidt W; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Schlundt C; Zimmermann S; Lonke S; von Cranach M; Markovic S; Daniel WG; Achenbach S; Wöhrle J
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1695-700. PubMed ID: 26476609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal treatment of renal artery in-stent restenosis: repeat stent placement versus angioplasty alone.
    N'Dandu ZM; Badawi RA; White CJ; Grise MA; Reilly JP; Jenkins JS; Collins TJ; Ramee SR
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):701-5. PubMed ID: 18360868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to treat recurrent renal artery instent restenosis? Editorial comment on treatment of reoccuring instent restenosis following reintervention after stent-supported renal artery angioplasty--article by Zeller et al.
    Schillinger M
    Catheter Cardiovasc Interv; 2007 Aug; 70(2):301-2. PubMed ID: 17630675
    [No Abstract]   [Full Text] [Related]  

  • 15. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
    Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-eluting stents versus bare metal stents for the prevention of restenosis in patients with renovascular disease.
    Bradaric C; Eser K; Preuss S; Dommasch M; Wustrow I; Langwieser N; Haller B; Ott I; Fusaro M; Heemann U; Laugwitz KL; Kastrati A; Ibrahim T
    EuroIntervention; 2017 Jun; 13(2):e248-e255. PubMed ID: 28044987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of renal artery in-stent restenosis with sirolimus-eluting stents.
    Kiernan TJ; Yan BP; Eisenberg JD; Ruggiero NJ; Gupta V; Drachman D; Schainfeld RM; Jaff MR; Rosenfield K; Garasic J
    Vasc Med; 2010 Feb; 15(1):3-7. PubMed ID: 19793778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does endovascular treatment of infra-inguinal arterial disease with drug-eluting stents offer better results than angioplasty with or without bare metal stents?
    Antoniou GA; Georgakarakos EI; Antoniou SA; Georgiadis GS
    Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):282-5. PubMed ID: 24729201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of transplant renal artery stenosis by percutaneous transluminal angioplasty and/or stenting: study in 63 patients in a single institution.
    Marini M; Fernandez-Rivera C; Cao I; Gulias D; Alonso A; Lopez-Muñiz A; Gómez-Martínez P
    Transplant Proc; 2011; 43(6):2205-7. PubMed ID: 21839234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.